199 related articles for article (PubMed ID: 16775188)
1. Barriers to full colon evaluation for a positive fecal occult blood test.
Fisher DA; Jeffreys A; Coffman CJ; Fasanella K
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1232-5. PubMed ID: 16775188
[TBL] [Abstract][Full Text] [Related]
2. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test.
Turner B; Myers RE; Hyslop T; Hauck WW; Weinberg D; Brigham T; Grana J; Rothermel T; Schlackman N
J Gen Intern Med; 2003 May; 18(5):357-63. PubMed ID: 12795734
[TBL] [Abstract][Full Text] [Related]
3. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?
Carlson CM; Kirby KA; Casadei MA; Partin MR; Kistler CE; Walter LC
Arch Intern Med; 2011 Feb; 171(3):249-56. PubMed ID: 20937917
[TBL] [Abstract][Full Text] [Related]
4. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
Miglioretti DL; Rutter CM; Bradford SC; Zauber AG; Kessler LG; Feuer EJ; Grossman DC
Med Care; 2008 Sep; 46(9 Suppl 1):S91-6. PubMed ID: 18725839
[TBL] [Abstract][Full Text] [Related]
5. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
[TBL] [Abstract][Full Text] [Related]
6. Role of double-contrast barium enema in colorectal cancer screening based on fecal occult blood.
Ciatto S; Castiglione G
Tumori; 2002; 88(2):95-8. PubMed ID: 12088265
[TBL] [Abstract][Full Text] [Related]
7. Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results.
Singh H; Kadiyala H; Bhagwath G; Shethia A; El-Serag H; Walder A; Velez ME; Petersen LA
Am J Gastroenterol; 2009 Apr; 104(4):942-52. PubMed ID: 19293786
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer screening among African-American and white male veterans.
Dolan NC; Ferreira MR; Fitzgibbon ML; Davis TC; Rademaker AW; Liu D; Lee J; Wolf M; Schmitt BP; Bennett CL
Am J Prev Med; 2005 Jun; 28(5):479-82. PubMed ID: 15894152
[TBL] [Abstract][Full Text] [Related]
9. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer screening, comorbidity, and follow-up in elderly patients.
Garman KS; Jeffreys A; Coffman C; Fisher DA
Am J Med Sci; 2006 Oct; 332(4):159-63. PubMed ID: 17031239
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
[TBL] [Abstract][Full Text] [Related]
12. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.
Gingold-Belfer R; Leibovitzh H; Boltin D; Issa N; Tsadok Perets T; Dickman R; Niv Y
United European Gastroenterol J; 2019 Apr; 7(3):424-448. PubMed ID: 31019712
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer screening.
Inger DB
Prim Care; 1999 Mar; 26(1):179-87. PubMed ID: 9922301
[TBL] [Abstract][Full Text] [Related]
14. Patient preferences for colorectal cancer screening.
Leard LE; Savides TJ; Ganiats TG
J Fam Pract; 1997 Sep; 45(3):211-8. PubMed ID: 9300000
[TBL] [Abstract][Full Text] [Related]
15. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
16. Is barium enema an adequate diagnostic test for the evaluation of patients with positive fecal occult blood?
Ramos C; De Jesús-Caraballo J; Toro DH; Ojeda A; Martínez-Souss J; Dueño MI; Cruz-Correa M
Bol Asoc Med P R; 2009; 101(2):23-8. PubMed ID: 19954097
[TBL] [Abstract][Full Text] [Related]
17. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.
Inadomi JM; Vijan S; Janz NK; Fagerlin A; Thomas JP; Lin YV; Muñoz R; Lau C; Somsouk M; El-Nachef N; Hayward RA
Arch Intern Med; 2012 Apr; 172(7):575-82. PubMed ID: 22493463
[TBL] [Abstract][Full Text] [Related]
18. Screening for colorectal cancer--now and the near future.
Bromer MQ; Weinberg DS
Semin Oncol; 2005 Feb; 32(1):3-10. PubMed ID: 15726501
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy.
Scheitel SM; Ahlquist DA; Wollan PC; Hagen PT; Silverstein MD
Mayo Clin Proc; 1999 Dec; 74(12):1207-13. PubMed ID: 10593348
[TBL] [Abstract][Full Text] [Related]
20. Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior?
James AS; Campbell MK; Hudson MA
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):529-34. PubMed ID: 12050093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]